603014 威高血净
已收盘 12-11 15:00:00
资讯
新帖
简况
威高血净（603014）披露使用暂时闲置募集资金进行现金管理到期赎回情况，12月2日股价下跌0.95%
证券之星 · 12-02
威高血净（603014）披露使用暂时闲置募集资金进行现金管理到期赎回情况，12月2日股价下跌0.95%
威高血净（603014）披露发行股份购买资产暨关联交易事项进展公告，11月28日股价上涨1.13%
证券之星 · 11-28
威高血净（603014）披露发行股份购买资产暨关联交易事项进展公告，11月28日股价上涨1.13%
每周股票复盘：威高血净（603014）拟对合营企业增资0.725亿元
证券之星 · 11-23
每周股票复盘：威高血净（603014）拟对合营企业增资0.725亿元
威高血净（603014）披露对合营企业同比例增资暨关联交易公告，11月20日股价下跌0.81%
证券之星 · 11-20
威高血净（603014）披露对合营企业同比例增资暨关联交易公告，11月20日股价下跌0.81%
威高血净(603014.SH)与泰尔茂中国拟对威高泰尔茂进行同比例增资
智通财经 · 11-20
威高血净(603014.SH)与泰尔茂中国拟对威高泰尔茂进行同比例增资
威高血净（603014）125.47万股限售股将于11月19日解禁，占总股本0.3%
证券之星 · 11-19
威高血净（603014）125.47万股限售股将于11月19日解禁，占总股本0.3%
每周股票复盘：威高血净（603014）125万股限售股将上市流通
证券之星 · 11-16
每周股票复盘：威高血净（603014）125万股限售股将上市流通
威高血净（603014）披露首次公开发行网下配售限售股上市流通公告，11月12日股价上涨0.79%
证券之星 · 11-12
威高血净（603014）披露首次公开发行网下配售限售股上市流通公告，11月12日股价上涨0.79%
威高股份：年内回购约1.29亿港元，关联收购待落地
面包财经 · 11-10
威高股份：年内回购约1.29亿港元，关联收购待落地
每周股票复盘：威高血净（603014）近5日三次登龙虎榜
证券之星 · 11-09
每周股票复盘：威高血净（603014）近5日三次登龙虎榜
股市必读：威高血净（603014）登11月6日交易所龙虎榜
证券之星 · 11-07
股市必读：威高血净（603014）登11月6日交易所龙虎榜
11月5日威高血净（603014）龙虎榜数据：游资余哥、粉葛上榜
证券之星 · 11-05
11月5日威高血净（603014）龙虎榜数据：游资余哥、粉葛上榜
威高血净（603014）披露股票交易异常波动公告，11月04日股价上涨10.0%
证券之星 · 11-04
威高血净（603014）披露股票交易异常波动公告，11月04日股价上涨10.0%
11月3日威高血净（603014）涨停分析：产业链整合、股权激励驱动
证券之星 · 11-03
11月3日威高血净（603014）涨停分析：产业链整合、股权激励驱动
威高血净(603014.SH)拟购买山东威高普瑞医药包装有限公司100%股权 股票复牌
智通财经 · 10-31
威高血净(603014.SH)拟购买山东威高普瑞医药包装有限公司100%股权 股票复牌
威高血净(603014)9月30日股东户数2.48万户，较上期减少20.95%
证券之星 · 10-31
威高血净(603014)9月30日股东户数2.48万户，较上期减少20.95%
图解威高血净三季报：第三季度单季净利润同比增长4.15%
证券之星 · 10-30
图解威高血净三季报：第三季度单季净利润同比增长4.15%
威高血净上市即买“兄弟公司”背后，稳健业绩也靠关联交易？
银莕财经 · 10-22
威高血净上市即买“兄弟公司”背后，稳健业绩也靠关联交易？
每周股票复盘：威高血净（603014）拟购普瑞医药100%股权并分红
证券之星 · 10-19
每周股票复盘：威高血净（603014）拟购普瑞医药100%股权并分红
威高血净（603014）披露筹划发行股份购买资产暨关联交易事项，10月17日股价下跌2.48%
证券之星 · 10-17
威高血净（603014）披露筹划发行股份购买资产暨关联交易事项，10月17日股价下跌2.48%
加载更多
公司概况
公司名称：
山东威高血液净化制品股份有限公司
所属行业：
专用设备制造业
上市日期：
2025-05-19
主营业务：
山东威高血液净化制品股份有限公司的主营业务是血液净化医用制品的研发、生产和销售。公司的主要产品是血液透析器、血液透析管路、血液透析机以及腹膜透析液。
发行价格：
26.50
{"stockData":{"symbol":"603014","market":"SH","secType":"STK","nameCN":"威高血净","latestPrice":41.83,"timestamp":1765436400000,"preClose":41.7,"halted":0,"volume":3114686,"delay":0,"changeRate":0.0031,"floatShares":39367300,"shares":418000000,"eps":1.1356,"marketStatus":"已收盘","change":0.13,"latestTime":"12-11 15:00:00","open":41.86,"high":42.46,"low":41.4,"amount":131000000,"amplitude":0.0254,"askPrice":41.83,"askSize":33,"bidPrice":41.82,"bidSize":48,"shortable":0,"etf":0,"ttmEps":1.1356,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765503000000},"marketStatusCode":5,"adr":0,"adjPreClose":41.7,"symbolType":"stock","openAndCloseTimeList":[[1765416600000,1765423800000],[1765429200000,1765436400000]],"highLimit":45.87,"lowLimit":37.53,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":417754066,"isCdr":false,"pbRate":2.5,"roa":"--","peRate":36.835153,"roe":"5.44%","epsLYR":1.21,"committee":-0.063063,"marketValue":17475000000,"turnoverRate":0.0791,"status":0,"floatMarketCap":1647000000},"requestUrl":"/m/hq/s/603014","defaultTab":"news","newsList":[{"id":"2588059415","title":"威高血净（603014）披露使用暂时闲置募集资金进行现金管理到期赎回情况，12月2日股价下跌0.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588059415","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588059415?lang=zh_cn&edition=full","pubTime":"2025-12-02 22:21","pubTimestamp":1764685267,"startTime":"0","endTime":"0","summary":"截至2025年12月2日收盘，威高血净报收于40.85元，较前一交易日下跌0.95%，最新总市值为170.65亿元。该股当日开盘41.24元，最高41.65元，最低40.8元，成交额达7319.78万元，换手率为4.52%。公司近日发布公告称，山东威高血液净化制品股份有限公司使用暂时闲置募集资金进行现金管理，近期赎回多笔结构性存款产品，合计赎回金额76,000万元，获得实际收益共计99.40万元。截至公告日，未到期现金管理余额为5,500万元，未超出董事会授权额度。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200039737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","603014"],"gpt_icon":0},{"id":"2586193738","title":"威高血净（603014）披露发行股份购买资产暨关联交易事项进展公告，11月28日股价上涨1.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586193738","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586193738?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:15","pubTimestamp":1764339340,"startTime":"0","endTime":"0","summary":"截至2025年11月28日收盘，威高血净报收于40.43元，较前一交易日上涨1.13%，最新总市值为168.9亿元。公司近日发布公告称，山东威高血液净化制品股份有限公司正在筹划以发行股份方式购买山东威高普瑞医药包装有限公司100%股权，本次交易构成重大资产重组及关联交易，不构成重组上市。公司股票曾于2025年10月20日起停牌，后于11月3日复牌。本次交易尚需董事会再次审议、股东会批准及监管机构核准，能否实施存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800039813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","603014"],"gpt_icon":0},{"id":"2585103677","title":"每周股票复盘：威高血净（603014）拟对合营企业增资0.725亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585103677","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585103677?lang=zh_cn&edition=full","pubTime":"2025-11-23 02:30","pubTimestamp":1763836236,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，威高血净报收于39.84元，较上周的41.58元下跌4.18%。山东威高血液净化制品股份有限公司拟与泰尔茂（中国）投资有限公司对合营企业威高泰尔茂（威海）医疗制品有限公司同比例增资，公司拟增资0.725亿元人民币。本次增资后，威高泰尔茂注册资本将由1.6亿元增至3.05亿元，公司持股比例保持50%不变。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603014","BK0251"],"gpt_icon":0},{"id":"2584413700","title":"威高血净（603014）披露对合营企业同比例增资暨关联交易公告，11月20日股价下跌0.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584413700","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584413700?lang=zh_cn&edition=full","pubTime":"2025-11-20 22:19","pubTimestamp":1763648359,"startTime":"0","endTime":"0","summary":"截至2025年11月20日收盘，威高血净报收于40.26元，较前一交易日下跌0.81%，最新总市值为168.19亿元。该股当日开盘40.6元，最高40.98元，最低40.09元，成交额达8127.26万元，换手率为5.1%。近日，山东威高血液净化制品股份有限公司发布公告称，公司拟与泰尔茂（中国）投资有限公司对合营企业威高泰尔茂（威海）医疗制品有限公司同比例增资，公司拟增资0.725亿元人民币。本次增资后，威高泰尔茂注册资本将由1.6亿元增至3.05亿元，公司持股比例保持50%不变。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000038185.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603014","BK0251"],"gpt_icon":0},{"id":"2584513184","title":"威高血净(603014.SH)与泰尔茂中国拟对威高泰尔茂进行同比例增资","url":"https://stock-news.laohu8.com/highlight/detail?id=2584513184","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584513184?lang=zh_cn&edition=full","pubTime":"2025-11-20 17:11","pubTimestamp":1763629898,"startTime":"0","endTime":"0","summary":"智通财经APP讯，威高血净(603014.SH)发布公告，结合公司战略规划，为满足腹膜透析液业务的发展需要，公司与泰尔茂中国拟对威高泰尔茂进行同比例增资，其中公司拟增资金额为0.725亿元人民币。本次增资完成后，威高泰尔茂的注册资本将由1.6亿元人民币增加至3.05亿元人民币，公司对威高泰尔茂的持股比例不变，仍为50%，威高泰尔茂仍属于公司与泰尔茂中国共同控制的合营企业。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1371602.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","603014"],"gpt_icon":0},{"id":"2584962206","title":"威高血净（603014）125.47万股限售股将于11月19日解禁，占总股本0.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584962206","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584962206?lang=zh_cn&edition=full","pubTime":"2025-11-19 08:05","pubTimestamp":1763510709,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，威高血净于11月19日将有125.47万股限售股份解禁，为公司首发机构配售股份，占公司总股本0.3%。本次解禁后，公司还有3.78亿股限售股份，占总股本90.58%。威高血净主营业务：专注于血液净化医用制品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900004946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","603014"],"gpt_icon":0},{"id":"2583010656","title":"每周股票复盘：威高血净（603014）125万股限售股将上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2583010656","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583010656?lang=zh_cn&edition=full","pubTime":"2025-11-16 01:47","pubTimestamp":1763228829,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，威高血净报收于41.58元，较上周的45.27元下跌8.15%。公司公告汇总山东威高血液净化制品股份有限公司首次公开发行网下配售限售股共计1,254,745股，占公司总股本0.3%，锁定期为6个月，将于2025年11月19日起上市流通。本次解除限售股份数量为1,254,745股，上市流通后有限售条件流通股相应减少，无限售条件流通股增加。保荐机构华泰联合证券对本次限售股上市流通无异议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600000298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","603014"],"gpt_icon":0},{"id":"2582370782","title":"威高血净（603014）披露首次公开发行网下配售限售股上市流通公告，11月12日股价上涨0.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582370782","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582370782?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:58","pubTimestamp":1762959496,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘，威高血净报收于43.13元，较前一交易日上涨0.79%，最新总市值为180.18亿元。该股当日开盘42.5元，最高43.57元，最低42.06元，成交额达1.78亿元，换手率为10.89%。公司近日发布公告称，山东威高血液净化制品股份有限公司首次公开发行网下配售限售股将于2025年11月19日上市流通。本次解除限售股份数量为1,254,745股，占公司总股本的0.3%，锁定期为6个月。相关股东已严格履行限售承诺，保荐机构对本次限售股上市流通无异议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200041866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","603014"],"gpt_icon":0},{"id":"2582384940","title":"威高股份：年内回购约1.29亿港元，关联收购待落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2582384940","media":"面包财经","labels":["shareholding","buyback","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582384940?lang=zh_cn&edition=full","pubTime":"2025-11-10 13:27","pubTimestamp":1762752420,"startTime":"0","endTime":"0","summary":"11月6日，威高股份（1066.HK）公告当日回购股份34万股。公开资料显示，截至11月6日，威高股份年内已累计回购2292.32万股，耗资约1.29亿港元。威高股份近日还披露了第三季度最新营运表现，截 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20251110/c672357377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["603014","BK0251"],"gpt_icon":0},{"id":"2582286913","title":"每周股票复盘：威高血净（603014）近5日三次登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2582286913","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582286913?lang=zh_cn&edition=full","pubTime":"2025-11-09 02:52","pubTimestamp":1762627933,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，威高血净报收于45.27元，较上周的38.61元上涨17.25%。本周，威高血净11月6日盘中最高价报49.01元。本周关注点交易信息汇总：威高血净近5个交易日内第3次登上龙虎榜。沪深交易所2025年11月5日公布的交易公开信息显示，威高血净因有价格涨跌幅限制的日换手率达到20%的前五只证券登上龙虎榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001084.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","603014"],"gpt_icon":0},{"id":"2581066015","title":"股市必读：威高血净（603014）登11月6日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2581066015","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581066015?lang=zh_cn&edition=full","pubTime":"2025-11-07 01:50","pubTimestamp":1762451434,"startTime":"0","endTime":"0","summary":"截至2025年11月6日收盘，威高血净报收于45.9元，上涨2.73%，换手率30.19%，成交量11.51万手，成交额5.34亿元。当日关注点来自交易信息汇总：11月6日主力资金净流入804.08万元，占总成交额1.51%。来自交易信息汇总：威高血净因日换手率达20%于11月6日登龙虎榜，近5个交易日内第3次上榜。龙虎榜上榜沪深交易所2025年11月6日公布的交易公开信息显示，威高血净因有价格涨跌幅限制的日换手率达到20%的前五只证券登上龙虎榜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700001175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","603014"],"gpt_icon":0},{"id":"2581429777","title":"11月5日威高血净（603014）龙虎榜数据：游资余哥、粉葛上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2581429777","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581429777?lang=zh_cn&edition=full","pubTime":"2025-11-05 17:28","pubTimestamp":1762334897,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年11月5日公布的交易公开信息显示，威高血净因有价格涨跌幅限制的日换手率达到20%的前五只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2025年11月5日收盘，威高血净报收于44.68元，下跌3.98%，换手率32.3%，成交量12.31万手，成交额5.59亿元。从龙虎榜公布的当日买卖数据来看，余哥、粉葛等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500029764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","603014"],"gpt_icon":0},{"id":"2580301127","title":"威高血净（603014）披露股票交易异常波动公告，11月04日股价上涨10.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580301127","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580301127?lang=zh_cn&edition=full","pubTime":"2025-11-04 22:04","pubTimestamp":1762265079,"startTime":"0","endTime":"0","summary":"截至2025年11月4日收盘，威高血净报收于46.53元，较前一交易日上涨10.0%，最新总市值为194.38亿元。该股当日开盘46.53元，最高46.53元，最低44.43元，成交额达7.27亿元，换手率为41.41%。公司近日发布股票交易异常波动公告，称公司股票于2025年11月3日、4日连续两个交易日内收盘价格涨幅偏离值累计超过20%，属于股票交易异常波动。公司董事、高管及控股股东在股票异动期间无买卖公司股票行为。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400038915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603014","BK0251"],"gpt_icon":0},{"id":"2580269595","title":"11月3日威高血净（603014）涨停分析：产业链整合、股权激励驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2580269595","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580269595?lang=zh_cn&edition=full","pubTime":"2025-11-03 15:21","pubTimestamp":1762154476,"startTime":"0","endTime":"0","summary":"证券之星消息，威高血净11月3日涨停收盘，收盘价42.3元。该股于9点25分涨停，未打开涨停，截止收盘封单资金为2.63亿元，占其流通市值16.29%。11月3日的资金流向数据方面，主力资金净流入2387.78万元，占总成交额50.21%，游资资金净流出1442.92万元，占总成交额30.34%，散户资金净流出944.85万元，占总成交额19.87%。近5日资金流向一览见下表：该股为医疗器械概念热股，当日医疗器械概念上涨0.83%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300014702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","603014"],"gpt_icon":0},{"id":"2579463974","title":"威高血净(603014.SH)拟购买山东威高普瑞医药包装有限公司100%股权 股票复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2579463974","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579463974?lang=zh_cn&edition=full","pubTime":"2025-10-31 19:11","pubTimestamp":1761909095,"startTime":"0","endTime":"0","summary":"智通财经APP讯，威高血净(603014.SH)发布公告，公司拟发行股份购买威高股份、威海盛熙和威海瑞明持有的山东威高普瑞医药包装有限公司(简称“威高普瑞”)100%股权。公司股票将于2025年11月3日(星期一)开市起复牌。本次交易完成后，公司可以通过整合标的公司技术积累和产品布局，将产品线扩展到医药包材领域。同时，本次交易完成后，通过充分协同上市公司自身中空纤维过滤技术优势与标的公司在生物制药领域的丰富客户资源，可以实现双方在生物制药滤器业务上产品技术储备与销售渠道的双向赋能，共同开拓以生物制药滤器为重点的生物制药上游业务市场。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1363818.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"威高血净(603014.SH)拟购买山东威高普瑞医药包装有限公司100%股权 股票复牌","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","603014"],"gpt_icon":0},{"id":"2579459722","title":"威高血净(603014)9月30日股东户数2.48万户，较上期减少20.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579459722","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579459722?lang=zh_cn&edition=full","pubTime":"2025-10-31 17:27","pubTimestamp":1761902865,"startTime":"0","endTime":"0","summary":"证券之星消息，近日威高血净披露，截至2025年9月30日公司股东户数为2.48万户，较6月30日减少6580.0户，减幅为20.95%。在医疗器械行业个股中，威高血净股东户数高于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.21万户。根据统计，威高血净2025年6月30日至2025年9月30日，主力资金净流出1.61亿元，游资资金净流入370.29万元，散户资金净流入1.58亿元。期间龙虎榜该股共上榜2次。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100036380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603014","BK0251"],"gpt_icon":0},{"id":"2579110659","title":"图解威高血净三季报：第三季度单季净利润同比增长4.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579110659","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579110659?lang=zh_cn&edition=full","pubTime":"2025-10-30 19:07","pubTimestamp":1761822462,"startTime":"0","endTime":"0","summary":"证券之星消息，威高血净2025年三季报显示，前三季度公司主营收入27.36亿元，同比上升3.45%；归母净利润3.41亿元，同比上升7.92%；扣非净利润3.33亿元，其中2025年第三季度，公司单季度主营收入9.71亿元，同比下降4.65%；单季度归母净利润1.21亿元，同比上升4.15%；单季度扣非净利润1.19亿元，负债率17.55%，投资收益3372.08万元，财务费用50.83万元，毛利率40.69%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000039472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603014"],"gpt_icon":0},{"id":"2577363475","title":"威高血净上市即买“兄弟公司”背后，稳健业绩也靠关联交易？","url":"https://stock-news.laohu8.com/highlight/detail?id=2577363475","media":"银莕财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577363475?lang=zh_cn&edition=full","pubTime":"2025-10-22 17:59","pubTimestamp":1761127140,"startTime":"0","endTime":"0","summary":"交易完成后，威高普瑞将成为威高血净的全资子公司。威高血净在公告中表示，本次交易预计构成重大资产重组，且为关联交易，但不会导致公司实际控制人的变更。同时，为了筹划本次重组，威高血净宣布自10月20日开市起停牌。不过，需要注意的是，在此次关联交易之前，威高血净的稳健业绩就有诸多关联交易的“保驾护航”。威高血净与威高股份也有着重大关联交易，互为客户和供应商。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-22/doc-infuuiim7941473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","603014"],"gpt_icon":0},{"id":"2576041390","title":"每周股票复盘：威高血净（603014）拟购普瑞医药100%股权并分红","url":"https://stock-news.laohu8.com/highlight/detail?id=2576041390","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576041390?lang=zh_cn&edition=full","pubTime":"2025-10-19 04:12","pubTimestamp":1760818329,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，威高血净报收于38.61元，较上周的38.84元下跌0.59%。本周关注点公司公告汇总：威高血净筹划发行股份购买威高普瑞100%股权，构成重大资产重组及关联交易。山东威高血液净化制品股份有限公司关于筹划发行股份购买资产暨关联交易事项的停牌公告山东威高血液净化制品股份有限公司因筹划发行股份购买山东威高普瑞医药包装有限公司100%股权，构成重大资产重组及关联交易，公司股票自2025年10月20日起停牌，预计不超过10个交易日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101900000868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603014","000978.SH","BK0251"],"gpt_icon":0},{"id":"2576051627","title":"威高血净（603014）披露筹划发行股份购买资产暨关联交易事项，10月17日股价下跌2.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576051627","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576051627?lang=zh_cn&edition=full","pubTime":"2025-10-17 22:40","pubTimestamp":1760712037,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，威高血净报收于38.61元，较前一交易日下跌2.48%，最新总市值为161.29亿元。该股当日开盘39.38元，最高39.68元，最低38.36元，成交额达8157.82万元，换手率为5.49%。公司近日发布公告称，因筹划发行股份购买山东威高普瑞医药包装有限公司100%股权，构成重大资产重组及关联交易，公司股票自2025年10月20日起停牌，预计不超过10个交易日。本次交易不构成重组上市，不会导致实际控制人变更。公司将按规定披露进展，提醒投资者注意风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101700038687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","603014"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765481643691,"stockEarnings":[{"period":"1week","weight":0.0195},{"period":"1month","weight":-0.0224},{"period":"3month","weight":0.0417},{"period":"6month","weight":0.1401},{"period":"1year","weight":0.5785},{"period":"ytd","weight":0.5785}],"compareEarnings":[{"period":"1week","weight":-0.0006},{"period":"1month","weight":-0.0323},{"period":"3month","weight":0.0007},{"period":"6month","weight":0.147},{"period":"1year","weight":0.1284},{"period":"ytd","weight":0.1556}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东威高血液净化制品股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"24821人(较上一季度减少20.95%)","perCapita":"1586股","listingDate":"2025-05-19","address":"山东省威海市环翠区威海火炬高技术产业开发区威高西路7号","registeredCapital":"41775万元","survey":" 山东威高血液净化制品股份有限公司的主营业务是血液净化医用制品的研发、生产和销售。公司的主要产品是血液透析器、血液透析管路、血液透析机以及腹膜透析液。","listedPrice":26.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"威高血净(603014)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供威高血净(603014)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"威高血净,603014,威高血净股票,威高血净股票老虎,威高血净股票老虎国际,威高血净行情,威高血净股票行情,威高血净股价,威高血净股市,威高血净股票价格,威高血净股票交易,威高血净股票购买,威高血净股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"威高血净(603014)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供威高血净(603014)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}